Related Experiment Videos
Thiazide diuretics: first-line therapy for hypertension.
L E Ramsay1, W W Yeo, P R Jackson
1University Department of Medicine and Pharmacology, Royal Hallamshire Hospital, Sheffield, UK.
Summary
Low-dose thiazides are a cost-effective first-line hypertension treatment, particularly for older adults and women. They effectively reduce vascular complications with minimal monitoring and good tolerability.
Area of Science:
- Cardiology
- Pharmacology
- Geriatrics
Background:
- Hypertension management requires effective and safe first-line therapies.
- Comparative data on various antihypertensive drug classes are crucial for clinical decision-making.
Purpose of the Study:
- To compare low-dose thiazides with other first-line antihypertensives (beta-blockers, ACE inhibitors, calcium antagonists, alpha-blockers).
- To evaluate simplicity, tolerability, efficacy, safety, and cost-effectiveness of these agents.
Main Methods:
- Systematic review of short-term comparative studies.
- Analysis of long-term trials focusing on vascular complications of hypertension.
Main Results:
- Thiazides demonstrate superior tolerability in patients over 60 and younger women.
- Thiazide-based regimens consistently reduce vascular complications and coronary events.
- Concerns regarding thiazide-induced biochemical changes and coronary events are unfounded.
Conclusions:
- Low-dose thiazides are a primary choice for hypertension in patients over 60 and younger women (excluding those with diabetes or gout).
- Beta-blockers are an equally acceptable alternative for younger men.
- Thiazides offer significant cost-effectiveness and minimal monitoring requirements.